- Home
- NMTC vs ATRA Comparison
NMTC vs ATRA Comparison
Compare NMTC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMTC | ATRA |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.5M | 38.9M |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NMTC | ATRA |
|---|---|---|
| Price | $0.77 | $4.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $1.98 | ★ $6.00 |
| AVG Volume (30 Days) | 163.5K | ★ 292.7K |
| Earning Date | 05-12-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.43 | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | $9,097,692.00 | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $31.90 | N/A |
| P/E Ratio | ★ N/A | $1.94 |
| Revenue Growth | ★ 163.47 | N/A |
| 52 Week Low | $0.40 | $3.92 |
| 52 Week High | $1.15 | $19.15 |
Technical Indicators
Market Signals| Indicator | NMTC | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 43.84 |
| Support Level | $0.69 | $4.27 |
| Resistance Level | $0.91 | $5.80 |
| Average True Range (ATR) | 0.05 | 0.68 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 34.83 | 11.15 |
Price Performance
Historical ComparisonAbout NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).